Cargando…
Tocotrienol supplementation in postmenopausal osteoporosis: evidence from a laboratory study
OBJECTIVE: Accelerated bone loss that occurs in postmenopausal women has been linked to oxidative stress and increased free radicals. We propose the use of antioxidants to prevent and reverse postmenopausal osteoporosis. This study aimed to examine the effects of tocotrienol, a vitamin E analog, on...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798611/ https://www.ncbi.nlm.nih.gov/pubmed/24212841 http://dx.doi.org/10.6061/clinics/2013(10)08 |
_version_ | 1782287800660393984 |
---|---|
author | Muhammad, Norliza Luke, Douglas Alwyn Shuid, Ahmad Nazrun Mohamed, Norazlina Soelaiman, Ima Nirwana |
author_facet | Muhammad, Norliza Luke, Douglas Alwyn Shuid, Ahmad Nazrun Mohamed, Norazlina Soelaiman, Ima Nirwana |
author_sort | Muhammad, Norliza |
collection | PubMed |
description | OBJECTIVE: Accelerated bone loss that occurs in postmenopausal women has been linked to oxidative stress and increased free radicals. We propose the use of antioxidants to prevent and reverse postmenopausal osteoporosis. This study aimed to examine the effects of tocotrienol, a vitamin E analog, on bone loss due to estrogen deficiency. Our previous study showed that tocotrienol increased the trabecular bone volume and trabecular number in ovariectomized rats. In the current study, we investigated the effects of tocotrienol supplementation on various biochemical parameters in a postmenopausal osteoporosis rat model. MATERIALS AND METHODS: A total of 32 female Wistar rats were randomly divided into four groups. The baseline group was sacrificed at the start of the study, and another group was sham operated. The remaining rats were ovariectomized and either given olive oil as a vehicle or treated with tocotrienol at a dose of 60 mg/kg body weight. After four weeks of treatment, blood was withdrawn for the measurement of interleukin-1 (IL1) and interleukin-6 (IL6) (bone resorbing cytokines), serum osteocalcin (a bone formation marker) and pyridinoline (a bone resorption marker). RESULTS: Tocotrienol supplementation in ovariectomized rats significantly reduced the levels of osteocalcin, IL1 and IL6. However, it did not alter the serum pyridinoline level. CONCLUSION: Tocotrienol prevented osteoporotic bone loss by reducing the high bone turnover rate associated with estrogen deficiency. Therefore, tocotrienol has the potential to be used as an anti-osteoporotic agent in postmenopausal women. |
format | Online Article Text |
id | pubmed-3798611 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo |
record_format | MEDLINE/PubMed |
spelling | pubmed-37986112013-10-22 Tocotrienol supplementation in postmenopausal osteoporosis: evidence from a laboratory study Muhammad, Norliza Luke, Douglas Alwyn Shuid, Ahmad Nazrun Mohamed, Norazlina Soelaiman, Ima Nirwana Clinics (Sao Paulo) Basic Research OBJECTIVE: Accelerated bone loss that occurs in postmenopausal women has been linked to oxidative stress and increased free radicals. We propose the use of antioxidants to prevent and reverse postmenopausal osteoporosis. This study aimed to examine the effects of tocotrienol, a vitamin E analog, on bone loss due to estrogen deficiency. Our previous study showed that tocotrienol increased the trabecular bone volume and trabecular number in ovariectomized rats. In the current study, we investigated the effects of tocotrienol supplementation on various biochemical parameters in a postmenopausal osteoporosis rat model. MATERIALS AND METHODS: A total of 32 female Wistar rats were randomly divided into four groups. The baseline group was sacrificed at the start of the study, and another group was sham operated. The remaining rats were ovariectomized and either given olive oil as a vehicle or treated with tocotrienol at a dose of 60 mg/kg body weight. After four weeks of treatment, blood was withdrawn for the measurement of interleukin-1 (IL1) and interleukin-6 (IL6) (bone resorbing cytokines), serum osteocalcin (a bone formation marker) and pyridinoline (a bone resorption marker). RESULTS: Tocotrienol supplementation in ovariectomized rats significantly reduced the levels of osteocalcin, IL1 and IL6. However, it did not alter the serum pyridinoline level. CONCLUSION: Tocotrienol prevented osteoporotic bone loss by reducing the high bone turnover rate associated with estrogen deficiency. Therefore, tocotrienol has the potential to be used as an anti-osteoporotic agent in postmenopausal women. Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2013-10 /pmc/articles/PMC3798611/ /pubmed/24212841 http://dx.doi.org/10.6061/clinics/2013(10)08 Text en Copyright © 2013 Hospital das Clínicas da FMUSP http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Basic Research Muhammad, Norliza Luke, Douglas Alwyn Shuid, Ahmad Nazrun Mohamed, Norazlina Soelaiman, Ima Nirwana Tocotrienol supplementation in postmenopausal osteoporosis: evidence from a laboratory study |
title | Tocotrienol supplementation in postmenopausal osteoporosis: evidence from a laboratory study |
title_full | Tocotrienol supplementation in postmenopausal osteoporosis: evidence from a laboratory study |
title_fullStr | Tocotrienol supplementation in postmenopausal osteoporosis: evidence from a laboratory study |
title_full_unstemmed | Tocotrienol supplementation in postmenopausal osteoporosis: evidence from a laboratory study |
title_short | Tocotrienol supplementation in postmenopausal osteoporosis: evidence from a laboratory study |
title_sort | tocotrienol supplementation in postmenopausal osteoporosis: evidence from a laboratory study |
topic | Basic Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798611/ https://www.ncbi.nlm.nih.gov/pubmed/24212841 http://dx.doi.org/10.6061/clinics/2013(10)08 |
work_keys_str_mv | AT muhammadnorliza tocotrienolsupplementationinpostmenopausalosteoporosisevidencefromalaboratorystudy AT lukedouglasalwyn tocotrienolsupplementationinpostmenopausalosteoporosisevidencefromalaboratorystudy AT shuidahmadnazrun tocotrienolsupplementationinpostmenopausalosteoporosisevidencefromalaboratorystudy AT mohamednorazlina tocotrienolsupplementationinpostmenopausalosteoporosisevidencefromalaboratorystudy AT soelaimanimanirwana tocotrienolsupplementationinpostmenopausalosteoporosisevidencefromalaboratorystudy |